In the above in vitro experiments, we demonstrated that PHLDA2 promoted CRC cell growth, inhibited apoptosis, promoted EMT, and inhibited autophagy partly through the PI3K/AKT signaling pathway. The gene discussed is PHLDA2; the disease is colorectal carcinoma.